374 related articles for article (PubMed ID: 33276788)
1. The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
Ballotti R; Cheli Y; Bertolotto C
Mol Cancer; 2020 Dec; 19(1):170. PubMed ID: 33276788
[TBL] [Abstract][Full Text] [Related]
2. Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy.
Wellbrock C; Arozarena I
Pigment Cell Melanoma Res; 2015 Jul; 28(4):390-406. PubMed ID: 25818589
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.
Cheli Y; Giuliano S; Fenouille N; Allegra M; Hofman V; Hofman P; Bahadoran P; Lacour JP; Tartare-Deckert S; Bertolotto C; Ballotti R
Oncogene; 2012 May; 31(19):2461-70. PubMed ID: 21996743
[TBL] [Abstract][Full Text] [Related]
4. MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment.
Riesenberg S; Groetchen A; Siddaway R; Bald T; Reinhardt J; Smorra D; Kohlmeyer J; Renn M; Phung B; Aymans P; Schmidt T; Hornung V; Davidson I; Goding CR; Jönsson G; Landsberg J; Tüting T; Hölzel M
Nat Commun; 2015 Nov; 6():8755. PubMed ID: 26530832
[TBL] [Abstract][Full Text] [Related]
5. MITF in melanoma: mechanisms behind its expression and activity.
Hartman ML; Czyz M
Cell Mol Life Sci; 2015 Apr; 72(7):1249-60. PubMed ID: 25433395
[TBL] [Abstract][Full Text] [Related]
6. The MITF regulatory network in melanoma.
Chauhan JS; Hölzel M; Lambert JP; Buffa FM; Goding CR
Pigment Cell Melanoma Res; 2022 Sep; 35(5):517-533. PubMed ID: 35771179
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 expression is regulated by microphthalmia-associated transcription factor (MITF) in nodular melanoma.
Vučinić D; Grahovac M; Grahovac B; Vitezić BM; Kovač L; Belušić-Gobić M; Zamolo G
Pathol Res Pract; 2022 Jan; 229():153725. PubMed ID: 34942512
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype.
Hartman ML; Talar B; Noman MZ; Gajos-Michniewicz A; Chouaib S; Czyz M
PLoS One; 2014; 9(4):e95157. PubMed ID: 24733089
[TBL] [Abstract][Full Text] [Related]
9. MITF induces escape from innate immunity in melanoma.
Sánchez-Del-Campo L; Martí-Díaz R; Montenegro MF; González-Guerrero R; Hernández-Caselles T; Martínez-Barba E; Piñero-Madrona A; Cabezas-Herrera J; Goding CR; Rodríguez-López JN
J Exp Clin Cancer Res; 2021 Mar; 40(1):117. PubMed ID: 33789714
[TBL] [Abstract][Full Text] [Related]
10. MITF reprograms the extracellular matrix and focal adhesion in melanoma.
Dilshat R; Fock V; Kenny C; Gerritsen I; Lasseur RMJ; Travnickova J; Eichhoff OM; Cerny P; Möller K; Sigurbjörnsdóttir S; Kirty K; Einarsdottir BÓ; Cheng PF; Levesque M; Cornell RA; Patton EE; Larue L; de Tayrac M; Magnúsdóttir E; Ögmundsdóttir MH; Steingrimsson E
Elife; 2021 Jan; 10():. PubMed ID: 33438577
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf.
Nakai N; Kishida T; Shin-Ya M; Imanishi J; Ueda Y; Kishimoto S; Mazda O
Gene Ther; 2007 Feb; 14(4):357-65. PubMed ID: 17024102
[TBL] [Abstract][Full Text] [Related]
12. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.
Falletta P; Sanchez-Del-Campo L; Chauhan J; Effern M; Kenyon A; Kershaw CJ; Siddaway R; Lisle R; Freter R; Daniels MJ; Lu X; Tüting T; Middleton M; Buffa FM; Willis AE; Pavitt G; Ronai ZA; Sauka-Spengler T; Hölzel M; Goding CR
Genes Dev; 2017 Jan; 31(1):18-33. PubMed ID: 28096186
[TBL] [Abstract][Full Text] [Related]
13. Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.
Müller J; Krijgsman O; Tsoi J; Robert L; Hugo W; Song C; Kong X; Possik PA; Cornelissen-Steijger PD; Geukes Foppen MH; Kemper K; Goding CR; McDermott U; Blank C; Haanen J; Graeber TG; Ribas A; Lo RS; Peeper DS
Nat Commun; 2014 Dec; 5():5712. PubMed ID: 25502142
[TBL] [Abstract][Full Text] [Related]
14. microRNA-155, induced by interleukin-1ß, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells.
Arts N; Cané S; Hennequart M; Lamy J; Bommer G; Van den Eynde B; De Plaen E
PLoS One; 2015; 10(4):e0122517. PubMed ID: 25853464
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.
Wellbrock C; Rana S; Paterson H; Pickersgill H; Brummelkamp T; Marais R
PLoS One; 2008 Jul; 3(7):e2734. PubMed ID: 18628967
[TBL] [Abstract][Full Text] [Related]
16. MITF: master regulator of melanocyte development and melanoma oncogene.
Levy C; Khaled M; Fisher DE
Trends Mol Med; 2006 Sep; 12(9):406-14. PubMed ID: 16899407
[TBL] [Abstract][Full Text] [Related]
17. Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma.
Gelmi MC; Verdijk RM; Houtzagers LE; van der Velden PA; Kroes WGM; Luyten GPM; Vu THK; Jager MJ
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240204
[TBL] [Abstract][Full Text] [Related]
18. Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.
Fernández-Barral A; Orgaz JL; Baquero P; Ali Z; Moreno A; Tiana M; Gómez V; Riveiro-Falkenbach E; Cañadas C; Zazo S; Bertolotto C; Davidson I; Rodríguez-Peralto JL; Palmero I; Rojo F; Jensen LD; del Peso L; Jiménez B
Neoplasia; 2014 Jun; 16(6):529-42. PubMed ID: 25030625
[TBL] [Abstract][Full Text] [Related]
19. SOX5 is involved in balanced MITF regulation in human melanoma cells.
Kordaß T; Weber CE; Oswald M; Ast V; Bernhardt M; Novak D; Utikal J; Eichmüller SB; König R
BMC Med Genomics; 2016 Feb; 9():10. PubMed ID: 26927636
[TBL] [Abstract][Full Text] [Related]
20. Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M.
Katoh I; Mírová A; Kurata S; Murakami Y; Horikawa K; Nakakuki N; Sakai T; Hashimoto K; Maruyama A; Yonaga T; Fukunishi N; Moriishi K; Hirai H
Neoplasia; 2011 Nov; 13(11):1081-92. PubMed ID: 22131883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]